Reproducibility of motor effects induced by successive subcutaneous apomorphine injections in Parkinson's disease
- PMID: 8477407
- DOI: 10.1097/00002826-199304000-00003
Reproducibility of motor effects induced by successive subcutaneous apomorphine injections in Parkinson's disease
Abstract
We performed a crossover study of apomorphine-induced motor response reproducibility in 10 parkinsonian patients with the "on-off" phenomenon. On 2 separate days, each patient received two successive identical s.c. apomorphine injections, the second injection being randomly administered either 10 or 80 min after the end of the first apomorphine-induced motor benefit. Latency (12.3 +/- 4.5 min) and duration (61.9 +/- 13.3 min) of motor effects were similar in all tests. A transient worsening of the parkinsonian state after a motor improvement induced by apomorphine occurred in most of the patients. Therefore, the duration and severity of the "off" period after a motor improvement does not seem to influence the efficacy of a second apomorphine administration.
Similar articles
-
The motor response to repeated apomorphine administration in Parkinson's disease.Clin Neuropharmacol. 1991 Jun;14(3):209-13. doi: 10.1097/00002826-199106000-00003. Clin Neuropharmacol. 1991. PMID: 2070362
-
Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's disease.Neurology. 1992 Jul;42(7):1287-90. doi: 10.1212/wnl.42.7.1287. Neurology. 1992. PMID: 1620335
-
Motor response following repeated apomorphine administration is reduced in Parkinson's disease.Clin Neuropharmacol. 1989 Feb;12(1):14-22. doi: 10.1097/00002826-198902000-00002. Clin Neuropharmacol. 1989. PMID: 2713864
-
A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.Clin Ther. 2005 Nov;27(11):1710-24. doi: 10.1016/j.clinthera.2005.11.016. Clin Ther. 2005. PMID: 16368444 Review.
-
Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001. Drugs Aging. 2004. PMID: 15323576 Review.
Cited by
-
Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience.Mov Disord Clin Pract. 2022 Oct 27;10(2):190-208. doi: 10.1002/mdc3.13593. eCollection 2023 Feb. Mov Disord Clin Pract. 2022. PMID: 36825043 Free PMC article. Review.
-
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations.CNS Drugs. 2019 Sep;33(9):905-918. doi: 10.1007/s40263-019-00661-z. CNS Drugs. 2019. PMID: 31473980 Free PMC article. Review.
-
Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson's Disease.J Parkinsons Dis. 2023;13(4):441-451. doi: 10.3233/JPD-230055. J Parkinsons Dis. 2023. PMID: 37182902 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical